Modelling the cost effectiveness and budget impact of uterine botulinum toxin injections versus conventional treatment in severe dysmenorrhoea: A French perspective

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 92a2e9acbff9fa8e-LAX IP: 118.31.43.22 UTC time: 2025-04-02T20:00:30+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4